Skip to main content
Veterinary Medicines

Rivalgin, 500mg/ml, Solution for injection

Authorised
  • Metamizole sodium monohydrate

Product identification

Medicine name:
Rivalgin, 500mg/ml, Solution for injection
RIVALGIN 500 mg/ml SOLUCION INYECTABLE
Active substance:
  • Metamizole sodium monohydrate
Target species:
  • Cattle
  • Pig
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Metamizole sodium monohydrate
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        48
        hour
      • Meat and offal
        12
        day
    • Pig
      • Meat and offal
        12
        day
    • Dog
  • Intravenous use
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        5
        day
    • Cattle
      • Milk
        48
        hour
      • Meat and offal
        12
        day
    • Pig
      • Meat and offal
        12
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BB02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Glass Vial 5 x 100.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3815 ESP
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0152/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Hungary
  • Iceland
  • Italy
  • Lithuania
  • Norway
  • Portugal
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."